Skip to main content

Allogene Therapeutics, Inc.

ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737287

In the last 90 days, Allogene Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 209 institutions reported holding it in 13F filings for Q2 2026, worth $652.0M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Allogene Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
174
+18 vs. Q3 2024
Shares held
188.7M
+24.3M (+14.8%) vs. Q3 2024
Total value
$401.9M
−$58.5M (−12.7%) vs. Q3 2024
New holders
32
62 more added
Sold out
14
42 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 174 institutions
Q1 2021: 169 institutionsQ2 2021: 182 institutionsQ3 2021: 169 institutionsQ4 2021: 177 institutionsQ1 2022: 180 institutionsQ2 2022: 161 institutionsQ3 2022: 192 institutionsQ4 2022: 168 institutionsQ1 2023: 176 institutionsQ2 2023: 171 institutionsQ3 2023: 155 institutionsQ4 2023: 170 institutionsQ1 2024: 161 institutionsQ2 2024: 175 institutionsQ3 2024: 156 institutionsQ4 2024: 174 institutionsQ1 2025: 171 institutionsQ2 2025: 158 institutionsQ3 2025: 170 institutionsQ4 2025: 172 institutionsQ1 2026: 209 institutionsQ2 2026: 209 institutions
Value heldQ4 2024: $401.9M
Q1 2021: $3.12BQ2 2021: $2.25BQ3 2021: $2.26BQ4 2021: $1.28BQ1 2022: $836.7MQ2 2022: $1.15BQ3 2022: $1.15BQ4 2022: $700.9MQ1 2023: $582.3MQ2 2023: $662.9MQ3 2023: $413.3MQ4 2023: $392.4MQ1 2024: $586.0MQ2 2024: $385.1MQ3 2024: $460.4MQ4 2024: $401.9MQ1 2025: $288.5MQ2 2025: $207.9MQ3 2025: $201.0MQ4 2025: $222.7MQ1 2026: $444.7MQ2 2026: $652.0M
Institutions holding ALLO and their total value by quarter
QuarterHoldersValue
Q2 2026209$652.0M
Q1 2026209$444.7M
Q4 2025172$222.7M
Q3 2025170$201.0M
Q2 2025158$207.9M
Q1 2025171$288.5M
Q4 2024174$401.9M
Q3 2024156$460.4M
Q2 2024175$385.1M
Q1 2024161$586.0M
Q4 2023170$392.4M
Q3 2023155$413.3M
Q2 2023171$662.9M
Q1 2023176$582.3M
Q4 2022168$700.9M
Q3 2022192$1.15B
Q2 2022161$1.15B
Q1 2022180$836.7M
Q4 2021177$1.28B
Q3 2021169$2.26B
Q2 2021182$2.25B
Q1 2021169$3.12B

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Allogene Therapeutics, Inc.; share changes are against Q3 2024.

Institutions holding ALLO in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Intech Investment Management LLC71,323$151.9K0.00%+29,992+72.6%Added
Brevan Howard Capital Management LP87,573$186.5K0.00%+24,515+38.9%Added
Partners Capital Investment Group, LLP93,248$198.6K0.01%−161,597−63.4%Reduced
Janus Henderson Group PLC102,349$218.5K0.00%00.0%Unchanged
Wells Fargo & Company104,593$222.8K0.00%+23,779+29.4%Added
Legal & General Group Plc112,235$239.1K0.00%00.0%Unchanged
Bourgeon Capital Management LLC118,700$252.8K0.05%−23,880−16.7%Reduced
Invesco Ltd.127,486$271.5K0.00%+8,359+7.0%Added
California State Teachers Retirement System135,554$288.7K0.00%+7,685+6.0%Added
Toroso Investments, LLC135,952$289.6K0.00%−6,795−4.8%Reduced
Macquarie Group Ltd146,779$313.0K0.00%00.0%Unchanged
RMB Capital Management, LLC149,577$318.6K0.01%00.0%Unchanged
LPL Financial LLC150,413$320.4K0.00%−1,487−1.0%Reduced
Susquehanna International Group, LLP153,602$327.2K0.00%+71,146+86.3%Added
XTX Topco Ltd158,537$337.7K0.03%+158,537New
Jane Street Group, LLC164,523$350.4K0.00%−273,198−62.4%Reduced
Rhumbline Advisers191,714$408.3K0.00%+17,527+10.1%Added
Vontobel Holding Ltd.195,457$416.3K0.00%+173,457+788.4%Added
Ameriprise Financial Inc201,943$430.1K0.00%+24,830+14.0%Added
Caxton Associates LP206,380$439.6K0.01%−35,722−14.8%Reduced
Alliancebernstein L.P.210,078$447.5K0.00%00.0%Unchanged
Coastal Bridge Advisors, LLC221,059$470.9K0.12%−184,788−45.5%Reduced
American Century Companies Inc232,356$494.9K0.00%+32,935+16.5%Added
Harold Davidson & Associates Inc.232,615$495.5K0.24%+232,615New
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.253,576$547.7K0.00%+16,880+7.1%Added
UBS Asset Management Americas Inc270,559$576.3K0.00%+41,753+18.2%Added
Swiss National Bank287,900$613.2K0.00%+23,000+8.7%Added
Nuveen Asset Management, LLC300,871$640.9K0.00%+46,632+18.3%Added
Mirae Asset Global ETFs Holdings Ltd.305,895$651.1K0.00%+58,331+23.6%Added
Bank of New York Mellon Corp330,769$704.5K0.00%+13,150+4.1%Added
Standard Life Aberdeen plc364,382$776.1K0.00%+364,382New
Rafferty Asset Management, LLC367,445$782.7K0.00%+50,499+15.9%Added
Susquehanna Fundamental Investments, LLC376,661$802.3K0.01%+376,661New
Cerity Partners LLC387,387$831.6K0.00%−44,995−10.4%Reduced
Raiffeisen Bank International AG430,000$903.0K0.01%+430,000New
Nordea Investment Management AB460,641$985.8K0.00%+9,635+2.1%Added
Zacks Investment Management480,874$1.02M0.01%−35,727−6.9%Reduced
Manufacturers Life Insurance Company, The484,715$1.03M0.00%−1,308−0.3%Reduced
TD Asset Management Inc545,388$1.16M0.00%−131,752−19.5%Reduced
Renaissance Technologies LLC554,541$1.18M0.00%−87,468−13.6%Reduced
Citigroup Inc716,236$1.53M0.00%+246,926+52.6%Added
Barclays PLC761,286$1.62M0.00%+418,313+122.0%Added
UBS Group AG796,491$1.70M0.00%+449,151+129.3%Added
BNP Paribas Arbitrage, SA849,658$1.81M0.00%+803,284+1,732.2%Added
Morgan Stanley998,596$2.13M0.00%−722,934−42.0%Reduced
Gilead Sciences, Inc.1,156,689$2.46M0.16%+1,156,689New
Bank of America Corp1,163,743$2.48M0.00%+579,818+99.3%Added
Charles Schwab Investment Management Inc1,188,838$2.53M0.00%+9,990+0.8%Added
DAFNA Capital Management LLC1,240,118$2.64M0.67%+190,000+18.1%Added
Northern Trust Corp1,305,232$2.78M0.00%+56,693+4.5%Added
Patient Square Capital LP1,489,909$3.17M1.19%+1,489,909New
Vestal Point Capital, LP1,500,000$3.19M0.19%00.0%Unchanged
Vida Ventures Advisors, LLC1,798,163$3.83M2.62%00.0%Unchanged
Goldman Sachs Group Inc2,106,577$4.49M0.00%−56,026−2.6%Reduced
Two Sigma Advisers, LP2,702,200$5.76M0.01%+291,800+12.1%Added
Two Sigma Investments, LP2,712,139$5.78M0.01%−85,831−3.1%Reduced
Frazier Life Sciences Management, L.P.2,867,750$6.11M0.25%00.0%Unchanged
Wildcat Capital Management, LLC2,920,787$6.22M2.46%00.0%Unchanged
Geode Capital Management, LLC3,232,618$6.89M0.00%+5,514+0.2%Added
Foresite Capital Management VI LLC3,448,275$7.34M3.27%+3,448,275New
Dimensional Fund Advisors LP3,561,626$7.59M0.00%+831,146+30.4%Added
JPMorgan Chase & Co3,736,132$7.96M0.00%−351,374−8.6%Reduced
Woodline Partners LP4,360,232$9.29M0.06%−4,068−0.1%Reduced
Price T Rowe Associates Inc4,485,572$9.55M0.00%−353,171−7.3%Reduced
Primecap Management Co4,927,340$10.5M0.01%−740,920−13.1%Reduced
Citadel Advisors LLC5,349,096$11.4M0.01%+309,502+6.1%Added
Capital World Investors6,896,552$14.7M0.00%00.0%Unchanged
State Street Corp7,249,966$15.4M0.00%+236,883+3.4%Added
Vanguard Group Inc8,000,692$17.0M0.00%−327,007−3.9%Reduced
Lynx1 Capital Management LP10,874,723$23.2M8.68%+4,672,349+75.3%Added
BlackRock, Inc.18,062,655$38.5M0.00%+289,910+1.6%Added
TPG GP A, LLC18,716,306$39.9M0.64%00.0%Unchanged
Pfizer Inc22,032,040$46.9M1.81%+22,032,040New
FMR LLC23,771,995$50.6M0.00%−6,254,961−20.8%Reduced
Perceptive Advisors LLC0$00.00%−2,725,000−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−1,634,838−100.0%Sold out
Superstring Capital Management LP0$00.00%−478,115−100.0%Sold out
Millennium Management LLC0$00.00%−258,002−100.0%Sold out
Prudential Financial Inc0$00.00%−214,495−100.0%Sold out
Alps Advisors Inc0$00.00%−175,285−100.0%Sold out
Engineers Gate Manager LP0$00.00%−47,773−100.0%Sold out
AQR Capital Management LLC0$00.00%−33,589−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−28,533−100.0%Sold out
Private Advisor Group, LLC0$00.00%−12,087−100.0%Sold out
Amundi0$00.00%−8,011−100.0%Sold out
nVerses Capital, LLC0$00.00%−3,100−100.0%Sold out
Comerica Bank0$00.00%−1,916−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−41−100.0%Sold out